Swiss-US Trade Surplus Hits Record CHF41 Billion in 2025 Despite Tariffs

Defying geopolitical gravity and aggressive protectionism, Switzerland’s economic engine has roared to a new high. The trade surplus with the United States shattered expectations in 2025, climbing to a staggering CHF 41.1 billion. This represents a historic peak for Swiss-US commercial relations, achieved even as Washington tightened the screws on foreign trade.

While the United States grapples with its trade balance, Swiss exporters have demonstrated remarkable resilience. Shipments to the US surged by 3.9%, reaching a total value of CHF 54.7 billion. In stark contrast, American imports into Switzerland plummeted by 5.7%, dropping to just CHF 13.3 billion. This widening gap underscores a critical dynamic: American consumers and industries remain voracious for high-quality Swiss goods, regardless of the political climate. The numbers paint a picture of an asymmetric relationship where Swiss precision continues to command a premium across the Atlantic, leaving US exporters struggling to find a foothold in the Alpine market.

Make no mistake: it is not cuckoo clocks or chocolate driving this economic juggernaut. The true power behind these numbers is the colossal Swiss pharmaceutical and chemical sector. In 2025, this industry alone accounted for a massive 53% of all Swiss exports, with the total value swelling by CHF 3.3 billion to hit CHF 152 billion. While Donald Trump fixates on watches, the reality is that American healthcare relies heavily on Swiss innovation.

However, the victory lap is not universal across all sectors. While pharma soars, traditional industries are feeling the squeeze. Exports of machinery, electronics, and the iconic Swiss watch industry faced declines, highlighting a dangerous dependence on a single sector. Yet, the sheer volume of high-value chemical exports was enough to offset these losses and propel the overall surplus to record heights. This sectorial divergence exposes a vulnerability in the Swiss economy: while we remain a global pharmacy, our industrial base faces headwinds that cannot be ignored.

The record surplus has placed Switzerland directly in the crosshairs of Donald Trump. In a rambling and combative address at the World Economic Forum in Davos, the former President lashed out at Bern, declaring, "They’re only good because of us." Trump’s rhetoric has translated into punitive action; he admitted to hiking tariffs to a punishing 39% simply because former Swiss President Karin Keller-Sutter "rubbed him the wrong way" during negotiations.

"She was very repetitive," Trump complained, recounting his refusal to accept Switzerland's size as an excuse for the trade imbalance. "I said yeah but you have a big, big deficit." This personal animosity has had real-world consequences. Although a framework agreement is now in place to slash these tariffs back to 15%, the clock is ticking. A legally binding deal must be signed by March 31, leaving Swiss negotiators walking a tightrope. The message from Washington is clear: Swiss prosperity is viewed not as a result of innovation, but as a product of American "largesse" that can be revoked at any moment.

Trump’s fixation on the CHF 41.1 billion goods surplus tells only half the story—a convenient omission for his protectionist narrative. When the lens widens to include services, the picture changes dramatically. The United States dominates the services trade, exporting an estimated $65 billion in services to Switzerland in 2024, compared to just $35 billion flowing the other way.

When these figures are combined, the massive American deficit evaporates, shrinking to a mere $8 billion. This reality check is crucial. While Swiss manufacturers fill American shelves with tangible goods, US firms are quietly billing Swiss clients billions for software, financial services, and intellectual property. Trump’s claim that Switzerland "makes 41 billion dollars on just us" ignores the massive revenue streams flowing back to US tech giants and service providers. This selective use of data fuels political fires but fails to reflect the complex, symbiotic economic reality between the two nations.

Beyond the US drama, Switzerland’s global trade footprint is shifting. While the US and European markets—particularly Germany, Austria, and Italy—saw export growth, demand in Asia is cooling. Exports to China, Japan, and Hong Kong have declined, signaling a pivot away from the East. Consequently, Switzerland’s total global trade surplus dipped from the 2024 record of CHF 60.6 billion to CHF 54.3 billion.

This contraction, combined with the volatility of US relations, serves as a stark warning. Switzerland cannot rest on the laurels of this year's record US figures. With a March 31 deadline looming for the tariff reduction deal and a volatile partner in the White House, the Alpine nation faces a precarious year. The strategy of relying on high-value pharma exports to the West is paying off for now, but in a world of trade wars and shifting alliances, diversification is not just an option—it is a survival imperative.